Biohaven Pharmaceuticals

Biohaven Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurological, immunological, obesity-related, and oncological diseases. Known for its patient-first culture and groundbreaking migraine therapies, Biohaven advances a diverse pipeline through cutting-edge science and strategic collaborations.